U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a long-time vaccine skeptic and former vaccine injury lawyer, criticized the program’s “Vaccine Court” for failing to quickly and fairly compensate individuals harmed by vaccines.
In a post on X, Kennedy said he is working with Attorney General Pam Bondi to restore the program to its “original congressional intent,” arguing that its current structure unfairly positions the Department of Health and Human Services (HHS), which he leads, as the defendant rather than vaccine manufacturers.
This move continues Kennedy’s sweeping efforts to reshape U.S. vaccine and health policy. In June, he dismissed all 17 members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, replacing them with seven appointees, including figures with histories of questioning vaccine safety. One of these members previously earned significant fees as an expert witness against Merck’s Gardasil vaccine, a case in which Kennedy played a key role.
Kennedy is also reportedly considering removing members of another influential health advisory panel, the U.S. Preventive Services Task Force. His tenure at HHS has intensified scrutiny due to his longstanding promotion of vaccine skepticism, including discredited claims linking vaccines to autism and false statements about fetal cells in the measles vaccine.
The announcement comes amid one of the worst U.S. measles outbreaks in decades, further fueling debate over vaccine safety, public health policy, and Kennedy’s leadership approach.


U.S. Halts Visa Processing for Afghan Nationals Amid Security Concerns
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Trump and Lula Discuss Trade, Sanctions, and Security in “Productive” Phone Call
Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas
National Guard Member Killed in White House-Area Shooting Sparks Terror Probe and Immigration Review
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Australia Releases New National AI Plan, Opts for Existing Laws to Manage Risks
U.S. Officials Say Afghan Suspect in D.C. National Guard Shooting Radicalized After Arrival
Australia Progresses AUKUS Review as U.S. Affirms Strong Support
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Cuba Reaffirms Anti-Drug Cooperation as Tensions Rise in the Caribbean 



